Mirada teams with R2 Technology

Article

U.K.-based Mirada Solutions and R2 Technology of Sunnyvale, CA, have agreed to integrate R2's OmniCAD computer-assisted diagnosis platform with Mirada's Standard Mammogram Form (SMF) technology to create the next generation of CAD systems for

U.K.-based Mirada Solutions and R2 Technology of Sunnyvale, CA, have agreed to integrate R2's OmniCAD computer-assisted diagnosis platform with Mirada's Standard Mammogram Form (SMF) technology to create the next generation of CAD systems for mammography. SMF, described by the two companies as being intrinsic to the tissue characteristics of the breast, provides an optimal starting point to develop robust CAD applications, executives from the two companies said. SMF is a standardized representation of a mammogram computed from the image intensities (film or digital) and imaging parameters of the system used to acquire the image. The SMF standardization technology enables the optimization of mammograms acquired on different systems at different times for analysis, quantification, and display.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.